PolyPid Ltd. Ordinary SharesPYPD

PolyPid Ltd. (Nasdaq: PYPD ) is an innovative biopharmaceutical company dedicated to elevating treatment effectiveness, right where care begins. The Company develops long-acting, controlled-release drugs designed to deliver therapy precisely at the site of care, addressing critical unmet medical needs across a wide and diverse pipeline spanning surgical care, metabolic diseases, and.

polypid.com